Rating History for ADARx Pharmaceuticals (ADRX) by Morgan Stanley
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 10/20/2026 | Michael E Ulz | New Coverage | Overweight (N/A) |
32.00 (N/A) |
17.65 (17.45) |
-1.13% | Details |
